Cell Regeneration

People are living longer lives than ever before. This is due, in part, to medical advances that have enabled more people to be saved from life-threatening diseases, injuries, and congenital conditions.
Leaders at the SAJAYA Clinic and the Center for Regenerative Medicine believe that regenerative medicine, which allows for the repair of diseased, injured, or congenitally defective tissues and organs, will become an important component of medical and surgical practice in the coming years. The SAJAYA Clinic is poised to create new models of health care and transform medicine and surgery by leveraging the potential of regenerative medicine.

The Future Of Regenerative Medicine At SAJAYA

Regenerative medicine is still a relatively new field of practice, representing a paradigm shift away from the traditional medical focus on disease and toward an emphasis on health reconstruction. The Center for Regenerative Medicine is leveraging its unique expertise, resources, and capabilities to build the world’s most advanced and innovative ecosystem for developing, manufacturing, and delivering novel regenerative biotherapeutics.

SAJAYA Clinics is focusing on a newly refreshed regenerative medicine strategy that emphasizes enhanced biomanufacturing capability, with technology platforms supporting the development of new biologics. Biologics are a new type of “drug” derived from living organisms and can potentially provide targeted healing with fewer side effects.

The SAJAYA Clinic’s biomanufacturing initiatives are led by the Center for Regenerative Medicine across seven prioritized technology platforms:

  • Nonmalignant Cellular Therapies for tissue replacement or repair, such as induced pluripotent stem cells (iPSC), mesenchymal stem cells (MSC), MSC-matrix combinations, and dendritic cells.
  • Malignant Cellular Therapies, such as cancer-targeting chimeric antigen receptor (CAR) -cells
  • Gene and Viral Therapies that make use of genetic engineering and viruses that have been re-engineered
  • Tissue Engineering for repair and restoration, which includes 3D printing, biomaterials, and bioengineering
  • Virus-based Phage Therapies that target multiple drug-resistant infections
  • Extracellular Vesicles are extracellular vesicles that are secreted by natural or engineered cells and can function as drug, protein, or gene transporters.
  • Synthetic Biology is the process of redesigning organism functions to meet medical needs.